CUSIP G39342103COMQ4 2025
12 filings · latest May 15, 2025
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Rhumbline Advisers | 13.4K | $12.7K |
| 4 | Feb 14, 2023 | Oasis Management Co Ltd. | 13G | 5.6% | 6.80M | SEC |
| 5 | Feb 3, 2023 | Jayhawk Capital Management, L.L.C. | 13G/A | 4.7% | 5.72M | SEC |
| 6 | Feb 3, 2023 | Pacific Alliance Group Ltd | 13G | 7.8% | 9.50M | SEC |
| 7 | May 31, 2022 | Golden Meditech Stem Cells (Bvi) Co Ltd | 13D/A | 64.9% | 78.87M | SEC |
| 8 | May 23, 2022 | Golden Meditech Stem Cells (Bvi) Co Ltd | 13D | 64.9% | 78.87M | SEC |
| 9 | Feb 15, 2022 | Jayhawk Capital Management, L.L.C. | 13G/A | — | — | SEC |
| 10 | Feb 11, 2021 | Jayhawk Capital Management, L.L.C. | 13G/A | 9.9% | 12.00M | SEC |
See the full Schedule 13D/13G history for Global Cord Blood Corp.
Unlock full history